< Terug naar vorige pagina

Octrooi

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine are disclosed for use in the treatment of cancer, especially in the treatment of cancer where the patient shows resistance, for example, in a patient with cells with a lowered level of nucleoside transporter proteins and/or with nucleoside kinase-deficient cells and/or with mycoplasma-infected cells and/or with cells with a raised level of thymidylate synthase.
Octrooi-publicatienummer: US9221866
Bron: USPTO
Jaar toekenning: 2015
Jaar van publicatie: 2015
Status: Toegewezen
Technologiedomeinen: Pharmaceuticals
Gevalideerd voor IOF-sleutel: Ja